---
$id: https://graph.org.ai/products/commodity/51111866
$type: Product
source: UNSPSC
code: "51111866"
title: "Sulprostone"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sulprostone

**UNSPSC Code**: 51111866
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue with the molecular formula C23H31NO7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 501Q5EQ1GM, chemically known as 16-phenoxy-omega-17,18,19,20-tetranor prostaglandin e2 methylsulfonylamide but generally known as sulprostone, which bears US NIH Compound Identifier 5312153. European Medicines Agency schedules Sulprostone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10760MIG. The term SULPROSTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules sulprostone in its Anatomical Therapeutic Chemical (ATC) Classification. SULPROSTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulprostone under HS 29375000 and SITC 54156. As of Q4 2014, SULPROSTONE remains the US FDA Preferred Term for this commodity. Sulprostone bears US NLM identifiers UMLS ID C0075628 and NCI Concept Code C84191. SMILES: S(=O)(=O)(NC(=O)CCC/C=C\CC1C(C(O)CC1=O)/C=C/C(O)COC1CCCCC1)C.

